Sun Pharma Buys Additional Stake In Taro, Will Tender Offer Follow?

NEW DELHI - Alkaloida Chemical, an indirect subsidiary of Mumbai-based Sun Pharmaceutical, has bought a 9.4 percent stake in Taro Pharmaceutical from Brandes Investment Partners, taking Sun's holdings of the Israeli generic drug maker to 34.4 percent as it attempts to complete an acquisition that has stalled over the offer price